Andrea DiFabio, Chief Legal Officer at Xenon Pharmaceuticals Inc. ($XENE), made one open market sale of common shares in the last year, totaling about $157 thousand. The most recent transaction occurred on March 10, 2026. This places her 8,899th among 11,678 insiders by sale value, well below the average of $8.6 million across 6 transactions per seller. She had no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | M | Common Shares | 3750 | $0.00 | 8,643.0000 | 79,247,976 | 76.64% | 0.00% |
| March 12, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | M | Restricted Share Units | 3750 | $0.00 | 11,250.0000 | 79,247,976 | 25.00% | 0.00% |
| March 13, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | S | Common Shares | 1342 | $55.23 | 7,301.0000 | 79,247,976 | 15.53% | 0.00% |
| March 10, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | S | Common Shares | 2607 | $60.11 | 4,893.0000 | 79,247,976 | 34.76% | 0.00% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | M | Common Shares | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Performance Share Units | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | M | Performance Share Units | 7500 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.01% |
| Jan. 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 79,247,976 | 9999.99% | 0.02% |
| Jan. 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 79,247,976 | 9999.99% | 0.10% |
| March 12, 2025 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 77,894,643 | 9999.99% | 0.02% |
| March 12, 2025 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 77,894,643 | 9999.99% | 0.10% |
| March 11, 2024 | Xenon Pharmaceuticals Inc. | $XENE | DiFabio Andrea | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |